Jurkat-Clone E6-1 In Vitro Protein Expression Analysis Assay (Western Blot)
CAT#: ITS-1122-YF5866
Target Cell Organism: Human
Target Cell Name: Jurkat-Clone E6-1
Assay Type: Gene and Protein Expression Assays
Assay Overview
This assay is to provide Jurkat-Clone E6-1-based In Vitro Protein Expression Analysis Assay (Western Blot) to accelerate our client's oncology projects. The assay will be customized according to the specific requirements. Please contact our scientists to discuss more details.
Target Cell Name
Jurkat-Clone E6-1
Target Cell Organism
Human
Target Cell Background
Jurkat, Clone E6-1 is a clone of the Jurkat-FHCRC cell line, a derivative of the Jurkat cell line, which was established from the peripheral blood of a 14-year-old, male, acute T-cell leukemia patient. This cell line can be used in immune system disorder research and immunology and immuno-oncology research.
Related Diseases
Acute Lymphoblastic Leukemia; ALL
Research Area
Oncology
Assay Name
In Vitro Protein Expression Analysis Assay (Western Blot)
Short Description
Jurkat-Clone E6-1-cell based In Vitro Protein Expression Analysis Assay (Western Blot)
Assay Description
For protein expression, western blotting and immunoassays have provided high-quality quantitative results. 2D gel electrophoresis
Assay Type
Gene and Protein Expression Assays
Assay Type Details
Following transcription, primary transcript RNA is converted into mature RNA by post-transcriptional modifications. Post-transcriptional modification includes three major steps namely the addition of a 5'cap, addition of a 3'polyadenylation tail and RNA splicing. Stability of RNA has been considered as very important for gene expression and proteins at the post-transcriptional level.